Updates are available Correction dated 2021-09-22
Click to view Correction: https://doi.org/10.1038/s41380-021-01305-9
-
Authors
de Almeida Augusto, Paulo Sérgio https://orcid.org/0000-0002-2303-4452
Pereira, Raissa Lima Gonçalves https://orcid.org/0000-0001-8312-7207
Caligiorne, Sordaini Maria https://orcid.org/0000-0002-4154-4237
Sabato, Brian https://orcid.org/0000-0003-0825-7604
Assis, Bruna Rodrigues Dias https://orcid.org/0000-0001-7270-0055
do Espírito Santo, Larissa Pires https://orcid.org/0000-0001-7830-9882
dos Reis, Karine Dias https://orcid.org/0000-0003-4335-0759
Castro Goulart, Gisele Assis https://orcid.org/0000-0003-0292-076X
de Fátima, Ângelo https://orcid.org/0000-0003-2344-5590
de Castro Lourenço das Neves, Maila https://orcid.org/0000-0003-4125-3736
Garcia, Frederico Duarte https://orcid.org/0000-0003-1926-9053
- License Information
-
More Information
Article History
Received: 18 February 2021
Revised: 3 June 2021
Accepted: 23 June 2021
First Online: 11 August 2021
Change Date: 22 September 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41380-021-01305-9
Competing interests
: AF, FDG, GACG, and MCLN have stocks and are members of the advisory board of Hargon Ltd., a company dedicated to the development of new treatments for mental health.
